MA39126A2 - Synthèse d'enantiomère de progestérone et d'intermédiaires de celui-ci - Google Patents

Synthèse d'enantiomère de progestérone et d'intermédiaires de celui-ci

Info

Publication number
MA39126A2
MA39126A2 MA39126A MA39126A MA39126A2 MA 39126 A2 MA39126 A2 MA 39126A2 MA 39126 A MA39126 A MA 39126A MA 39126 A MA39126 A MA 39126A MA 39126 A2 MA39126 A2 MA 39126A2
Authority
MA
Morocco
Prior art keywords
progesterone
intermediates
enantiomeric synthesis
enantiomeric
synthesis
Prior art date
Application number
MA39126A
Other languages
English (en)
Other versions
MA39126A3 (fr
MA39126B1 (fr
Inventor
Daniel Levy
Faliang Zhang
Xinxi Zhan
Original Assignee
Prevacus Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prevacus Inc filed Critical Prevacus Inc
Publication of MA39126A2 publication Critical patent/MA39126A2/fr
Publication of MA39126A3 publication Critical patent/MA39126A3/fr
Publication of MA39126B1 publication Critical patent/MA39126B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/26—Radicals substituted by doubly bound oxygen or sulfur atoms or by two such atoms singly bound to the same carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • C07J15/005—Retrosteroids (9 beta 10 alfa)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • C07J75/005—Preparation of steroids by cyclization of non-steroid compounds

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)

Abstract

La présente invention concerne la synthèse d'enantiomère de progestérone et d'intermédiaires de celui-ci.
MA39126A 2013-12-20 2014-12-17 Synthèse d'enantiomère de progestérone et d'intermédiaires de celui-ci MA39126B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361919420P 2013-12-20 2013-12-20
PCT/US2014/070879 WO2015095339A1 (fr) 2013-12-20 2014-12-17 Synthèse d'enantiomère de progestérone et d'intermédiaires de celui-ci

Publications (3)

Publication Number Publication Date
MA39126A2 true MA39126A2 (fr) 2018-08-31
MA39126A3 MA39126A3 (fr) 2019-04-30
MA39126B1 MA39126B1 (fr) 2020-03-31

Family

ID=53399300

Family Applications (1)

Application Number Title Priority Date Filing Date
MA39126A MA39126B1 (fr) 2013-12-20 2014-12-17 Synthèse d'enantiomère de progestérone et d'intermédiaires de celui-ci

Country Status (18)

Country Link
US (1) US20150175650A1 (fr)
EP (1) EP3083656A1 (fr)
JP (1) JP2017502031A (fr)
CN (1) CN105980396B (fr)
AR (1) AR098879A1 (fr)
AU (1) AU2014364850A1 (fr)
BR (1) BR112016014000A2 (fr)
CA (1) CA2934466A1 (fr)
EA (1) EA201691074A1 (fr)
IL (1) IL246258A0 (fr)
MA (1) MA39126B1 (fr)
MX (1) MX2016008167A (fr)
PH (1) PH12016501201A1 (fr)
SG (1) SG11201604982XA (fr)
TN (1) TN2016000252A1 (fr)
TW (1) TW201538519A (fr)
UY (1) UY35909A (fr)
WO (1) WO2015095339A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017100988A (ja) * 2015-12-01 2017-06-08 アサヒグループホールディングス株式会社 光学活性なヒドロキシ脂肪酸の製造方法
IT201700004904A1 (it) * 2017-01-18 2018-07-18 Ind Chimica Srl PROCESSO PER LA PREPARAZIONE DI 9β,10α-PROGESTERONE (RETROPROGESTERONE)
MX2022001449A (es) * 2019-08-02 2022-04-06 Enterin Inc Compuestos de aminoesterol humano ent-03, composiciones relacionadas que comprenden los mismos y metodos para usar los mismos.
EP4007765A4 (fr) * 2019-08-02 2023-08-23 Enterin, Inc. Dérivés de squalamine humaine, compositions associées les comprenant, et procédés d'utilisation correspondants

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009219230A1 (en) * 2008-02-26 2009-09-03 Emory University Steroid analogues for neuroprotection
US20110306579A1 (en) * 2009-01-30 2011-12-15 Emory University Methods of neuroprotection using neuroprotective steroids and a vitamin d
US20130090317A1 (en) * 2011-10-07 2013-04-11 Florida State University Research Foundation Prophylactic and post-acute use of progesterone in conjunction with its enantiomer for use in treatment of traumatic brain injuries

Also Published As

Publication number Publication date
MA39126A3 (fr) 2019-04-30
MA39126B1 (fr) 2020-03-31
EA201691074A1 (ru) 2017-02-28
CA2934466A1 (fr) 2015-06-25
BR112016014000A2 (pt) 2017-08-08
CN105980396B (zh) 2019-03-22
MX2016008167A (es) 2017-04-27
AR098879A1 (es) 2016-06-22
IL246258A0 (en) 2016-08-02
CN105980396A (zh) 2016-09-28
TN2016000252A1 (en) 2017-10-06
US20150175650A1 (en) 2015-06-25
WO2015095339A1 (fr) 2015-06-25
PH12016501201A1 (en) 2016-08-15
EP3083656A1 (fr) 2016-10-26
UY35909A (es) 2015-07-31
AU2014364850A1 (en) 2016-07-07
JP2017502031A (ja) 2017-01-19
SG11201604982XA (en) 2016-07-28
TW201538519A (zh) 2015-10-16

Similar Documents

Publication Publication Date Title
MA39095A1 (fr) Anticorps et immunoconjugués anti-cd33
MA43018B1 (fr) Anticorps anti-pd1 et procédés d'utilisation
MA40682A (fr) Anticorps anti-ox40 et procédés d'utilisation correspondants
TWD179057S (zh) 充電器
MA40576B1 (fr) Anticorps et immunoconjugués anti-her2
MA38632B1 (fr) Anticorps anti-récepteur de transferrine et procédés d'utilisation
TWD180147S (zh) 淨水器
UY34721A (es) Anticuerpos anti-hla-b*27 y usos de éstos.
TWD182434S (zh) 修枝剪刀(一)
IN2013MU00848A (fr)
TWD174041S (zh) 手錶
PH12016500683A1 (en) Synthetic route to 2`-deoxy-2`,2`-difluorotetrahydrouridines
TWD174040S (zh) 錶
MA39126A3 (fr) Synthèse d'enantiomère de progestérone et d'intermédiaires de celui-ci
TWD187227S (zh) 淨水器
MA39411A (fr) Synthèse de l'énantiomère de la progestérone et ses intermédiaires
EA201690263A1 (ru) Улучшенные способы получения перампанеля
TWD166471S (zh) 手錶
TWD176865S (zh) 滴定儀器
MX2015012902A (es) Sintesis de ent-progesterona e intermediarios de la misma.
MA39355B2 (fr) Anticorps anti-ox40 et procédés d'utilisation correspondants
MX2016005511A (es) Intermediarios y metodos para sintetizar derivados de calicheamicina.
TWD173011S (zh) 手錶
MA38492A1 (fr) Anticorps et immunoconjugués anti-b7-h4
TWD180960S (zh) 淨水器